RecruitingNCT06467149

Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools

Sponsor

Ju Qiu

Enrollment

500 participants

Start Date

Aug 12, 2023

Study Type

OBSERVATIONAL

Conditions

Frailty Syndrome

Summary

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different tools used to screen for frailty — physical and functional weakness — in older patients with breast cancer, to identify which tools best predict complications after surgery and chemotherapy. **You may be eligible if...** - You are 50 years or older - You have been diagnosed with breast cancer - Your treatment plan includes both surgery and chemotherapy - You can walk on your own (with or without a walking aid) **You may NOT be eligible if...** - You have communication or mental health issues that prevent normal cooperation - You have another active cancer at the same time - You are in the terminal stage of your illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.